GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Oncology market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Oncology market reports here.

Cervical Cancer – Epidemiology Forecast to 2030

  • $3,995
  • January 2022
There were 109,891 cases of diagnosed incident cases of cervical cancer in the 8MM in 2020. The number of diagnosed incident cases is expected to increase further at an annual...

Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) – Global Clinical Trials Review, 2022

  • $2,500
  • January 2022
GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2022" provides an overview of Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical trials scenario. This report provides top line...

T-Cell Lymphomas: Epidemiology Forecast to 2030

  • $3,995
  • January 2022
In the 8MM, the diagnosed incident cases of TCL are expected to increase from 27,263 cases in 2020 growing at an Annual Growth Rate (AGR) of more than 2% during...

Neuroendocrine Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update

  • $2,500
  • December 2021
Global Markets Direct’s, ‘Neuroendocrine Tumors - Drugs In Development, 2021’, provides an overview of the Neuroendocrine Tumors pipeline landscape. The report provides comprehensive information on the therapeutics under development for...

Brain Cancer – Epidemiology Forecast to 2030

  • $3,995
  • December 2021
The global and historical trends for brain cancer are in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China). In the eight major markets...

Chronic Myeloid Leukemia (CML): Global Drug Forecast and Market Analysis to 2030

  • $10,995
  • December 2021
The 8MM CML market was valued at $4.25 billion in 2020, and expects sales to peak in 2023, before falling at a CAGR of more than -3% during the period...

Chronic Myeloid Leukemia: Epidemiology Forecast to 2030

  • $3,995
  • December 2021
In the eight major markets (8MM), the diagnosed incident cases of CML are expected to increase from 15,515 cases in 2020, at an Annual Growth Rate (AGR) of more than...

Glioblastoma Multiforme: Global Drug Forecast and Market Analysis to 2030

  • $10,995
  • December 2021
The glioblastoma multiforme (GBM) market at $549.1 million in 2020 across the 8MM. This does not include sales of imaging-enhancing agents such as 5-aminolevulinic acid, corticosteroids, or Optune TTF, which...

Glioblastoma Multiforme (GBM) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, H2, 2021" provides an overview of Glioblastoma Multiforme (GBM) Clinical trials scenario. This report provides top line data...